Skip to content

Insider · CIK 0001812305

Guy Levy

owner

Files at PBLS (Parabilis Medicines, Inc.). First filing Jun 29, 2026, latest Jun 29, 2026.

In brief

Guy Levy files SEC Form 4 as 10% owner at PBLS (Parabilis Medicines, Inc.). Since Jun 29, 2026, Guy Levy has reported 1 open-market buy worth $10M and 0 open-market sells worth $0, the latest filed on Jun 29, 2026.

A track record needs three past buys with six months of prices behind them; Guy Levy has 0, so none is measured yet.

The newest scored trade: bought $10M of PBLS on Jun 11, 2026, filed Jun 29, 2026, scored 57 (moderate). In the last 12 months: 1 buy worth $10M and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$10M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PBLS: Parabilis Medicines, Inc.

PBLSOct 13, 2026 · close 26.85

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
57Moderate
PBLSbuy 3
Parabilis Medicines, Inc.
$10M
500,000 shares
+77%-

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 11, 2026PBLS
Parabilis Medicines, Inc.
POpen-market purchase
Common Stock, par value $0.0001 per shareindirect: See footnote
+375,000$20.00$7.5M1,027,000Jun 29, 2026
Jun 11, 2026PBLS
Parabilis Medicines, Inc.
POpen-market purchase
Common Stock, par value $0.0001 per shareindirect: See footnote
+125,000$20.00$2.5M652,000Jun 29, 2026
Jun 11, 2026PBLS
Parabilis Medicines, Inc.
CConversion
Common Stock, par value $0.0001 per shareindirect: See footnote
+527,070$9.48$5.0M527,070Jun 29, 2026
Jun 11, 2026PBLS
Parabilis Medicines, Inc.
CConversion
Series F Preferred Stockderivativeindirect: See footnote
-527,070$0.00$00Jun 29, 2026

Questions about Guy Levy

Answered from the filings on this page, as of the latest one.

Is Guy Levy buying or selling?

In the last 12 months Guy Levy reported 1 open-market buy worth $10M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10M of PBLS on Jun 11, 2026. Grants, option exercises and tax withholding are not counted.

How did Guy Levy's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Guy Levy has 0.

Where does Guy Levy file Form 4?

Guy Levy has filed Form 4 at PBLS (Parabilis Medicines, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Guy Levy: insider trades and track record | InsiderTell